Immundiagnostik, Inc. has partnered with Epitope Diagnostics, Inc. (EDI) to offer the ECL100, a fully automated chemiluminescent immunoassay analyzer, and 50+ CLIA kits to laboratories across North ...
GlobalData on MSN
Biodesix and Bio-Rad expand collaboration for IVD assays development
Biodesix has expanded its collaboration with Bio-Rad for the development and clinical validation of in vitro diagnostic (IVD) ...
Pharmaceutical Technology on MSN
FDA greenlight for Roche’s Alzheimer’s disease test sparks care paradigm shift
The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost ...
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing ...
The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For ...
Pritelivir demonstrated numerically improved efficacy relative to foscarnet, and a more favourable safety and tolerability ...
Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which ...
NexMetals Mining Corp. (TSXV: NEXM) (NASDAQ: NEXM) (the “Company” or “NEXM”) is pleased to announce that final concentrate ...
Analyzed Limestone Meets Industrial Specifications for Several Saleable Products, Unlocking Value for Updated PEA Expected in Q1 2026 ...
NexMetals Mining Corp. is a mineral exploration and development company that is focused on the redevelopment of the previously producing copper, nickel and cobalt resources mines owned by the Company ...
Expands commercial readiness and diagnostic, manufacturing footprint Appoints new leadership in commercial strategy and ...
Canuc Resources Corporation (TSXV: CDA) (OTCQB: CNUCF) (WKN: A14ZX4) (“Canuc” or the “Company”) is pleased to report on the positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback